Etanercept: A viable treatment option for young children with generalized pustular psoriasis
Etanercept: A viable treatment option for young children with generalized pustular psoriasis
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Chinese data indicate that the prevalence and incidence of GPP follow a bimodal age distribution, with peaks in the 0–3 year age group and the 30–39 year age group.1 In the 0–3 year age group, the prevalence was 0.927 and the incidence rate was 0.742 per 100 000 population-years.1 Interleukin (IL)-36 plays an important role in GPP by activating nuc...
Alternative Titles
Full title
Etanercept: A viable treatment option for young children with generalized pustular psoriasis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9b63eaae394c472e994bcea4ad0deb9c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b63eaae394c472e994bcea4ad0deb9c
Other Identifiers
ISSN
2574-2272,2096-3726
E-ISSN
2574-2272
DOI
10.1002/ped4.12448
